Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review. - Syrowatka A; Song W; Amato MG; Foer D; Edrees H; Co Z; Kuznetsova M; Dulgarian S; Seger DL; Simona A; Bain PA; Purcell Jackson G; et al. (The Lancet. Digital health, 2022)